Rare disease drug approval: A second chance worth taking
Rare disease drug approval is back in the spotlight as a once-spurned treatment gets a second chance at regulatory approval.
Health Blog
Rare disease drug approval is back in the spotlight as a once-spurned treatment gets a second chance at regulatory approval.
Cancer drug prices are set to fall significantly after new margin caps.
Cheaper medicines are possible! Discover the proven strategies for lowering drug costs without price controls.
Cancer drugs price cut may lead to significant savings for patients in India, making treatment more affordable and accessible.
Aurobindo Pharma approval is a significant milestone for the company, boosting its product portfolio.
Linde India acquisition brings new gas supply benefits to the industry.
Dr. Reddy’s Abatacept Biosimilar approval is a game changer for the company.